Cargando…
β-Blockade for Patients with Hypertension, Ischemic Heart Disease or Heart Failure: Where are We Now?
β-blockers are a heterogeneous class of drugs, with varying selectivity/specificity for β(1) vs β(2) receptors, intrinsic sympathomimetic activity (ISA), and vasodilatory properties (through β(2) stimulation, α receptor blockade or nitric oxide release). These drugs are indicated for the management...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197620/ https://www.ncbi.nlm.nih.gov/pubmed/34135591 http://dx.doi.org/10.2147/VHRM.S285907 |